Screening Strategies in Drug Discovery – Webinars and Online Events

In this exclusive extended webinar, immerse yourself in a world of innovation as our expert speakers unveil state-of-the-art systems and workflows designed to optimize screening assays with unparalleled throughput and reproducibility.

Using data from a recent study, our expert speaker will demonstrate how the new readout platform improves ligand hit quality, and how TIMS offers potential for an expanded scope of AS-MS assays.

To support the development of mRNA-based therapies scientists require platforms that will help to address the selectivity and capacity requirements for the large-scale manufacturing of mRNA used in vaccine and gene therapy applications.

RNA dependent RNA polymerase (RdRp), is essential in the RNA replication within the life cycle of the severely acute respiratory coronavirus-2 (SARS-CoV-2), causing the deadly respiratory induced sickness COVID-19.

In this webinar series, speakers describe the development of an in-house 3D drug sensitivity and resistance testing platform, the development of a pipeline to functionally evaluate 3D organoid models from patients with genitourinary tumors, and how to better understand your 3D cell models and make insightful discoveries.

Now in its second year, this online symposium will provide those working within academia and pharmaceutical development the opportunity to hear from experts within the field. Focus will be given to the latest advances in small molecule drug discovery and development, biopharma and biotechnology

This webinar will focus on the development of HCS assays for CKD. Assays to monitor the dynamics of TNF signaling in human kidney podocytes will be explored, together with assays for ER stress and apoptosis in diabetic nephropathy.

It’s not by chance that biophysical methods are becoming an integral part of drug discovery workflows. Targets are becoming more diverse and challenging, demand for fragment-based screening projects is increasing, and the need to identify ligands with different mechanisms of action is rising. Biophysical methods can overcome the obstacles faced with challenging targets and ligands during lead identification.

We will explore how these advances are being utilized, both individually and in tandem, as we discuss a variety of new applications demonstrating the benefits of this improved, fully integrated system.

We will explore how these advances are being utilized, both individually and in tandem, as we discuss a variety of new applications demonstrating the benefits of this improved, fully integrated system.